Shire Regenerative Medicine Inc is categorized under Research and Development Laboratories in La Jolla, CA .
Shire Regenerative Medicine Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Jennifer Cassidy at the company’s branch by writing to 10933 North Torrey Pines Road, La Jolla, California CA 92037 or by phoning (858) 202-0673. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shire Regenerative Medicine Inc |
| Contact Person: | Jennifer Cassidy |
| Address: | 10933 North Torrey Pines Road, La Jolla, California 92037 |
| Phone Number: | (858) 202-0673 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Shire Regenerative Medicine Inc was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jennifer Cassidy for inquiries that concern Shire Regenerative Medicine Inc by calling the company number (858) 202-0673, as your correspondence is most welcome. Additionally, the physical location of the branch of Shire Regenerative Medicine Inc can be found at the coordinates 32.901881,-117.242471 as well as the street address 10933 North Torrey Pines Road in La Jolla, California 92037.
For its online presence, you may visit Shire Regenerative Medicine Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.